PHCEU brings advanced CO2 incubation to Advanced Therapies Congress


PHCEU brings advanced CO2 incubation to Advanced Therapies Congress


PHC Europe Logo 160 x 18

Press Release | PHC Europe BV

MAY 10, 2019

Etten-Leur, The Netherlands: – Biomedical preservation specialist PHC Europe B.V. (PHCEU) will be a prominent presence at the 2019 World Advanced Therapies and Regenerative Medicine Congress & Expo (WATRMC) in London.

The PHCEU stand at Booth 43a at London’s Business Design Center will showcase the company’s wide portfolio of PHCbi CO2 incubators, Multigas incubators and cryogenic storage incubators.

IncuSafe stars

Stars of the display will be the recently introduced PHCbi MCO-170AICUVH and the MCO-170AICUVD IncuSafe incubators that feature innovative technologies, including built in UV lighting, germicidal interior surfaces, H2O2 decontamination and password-protected security closure.

In addition, the latter IncuSafe also features Dual heat sterilisation using twin heaters to achieve an 11-hour 180°C sterilisation process, with no effect on temperature inside stacked incubators due to low heat dissipation.

Reliability and reproducibility

The PHCEU team will be emphasizing high applicability of PHCbi (previously Panasonic) ultra-low temperature and CO2 incubation technologies to the stem cell and regenerative medicine sectors covered by the conference.

The exhibition team will show how PHC Europe continues to respond to the needs of pharmaceutical, biotechnology and healthcare customers with fast delivery, in-depth back up and service, optimal cell culture results and the most secure storage for valuable samples. They will lay particular emphasis on market-leading reliability and reproducibility.

About PHCEU

Netherlands-based PHC Europe BV (PHCEU) is the European and African arm of the international PHC Corporation, whose PHCbi products are recognized worldwide as a leading and trusted brand for reliable, high-quality medical and laboratory equipment, with particular focus on technologies for preservation, incubation, sterilization and healthcare.

The company’s mission is to provide a leading, trusted brand for sustainable healthcare and biomedical product solutions, supporting the work of its customers to improve the health and well-being of people around the world.

PHCEU solutions range from excellent sample security in an ultra-low temperature (ULT) freezer or the best environment for cell culture in a CO2 incubator, while its relationships span the pharmaceutical, healthcare and biotechnology sectors, with a pan-continental supply and support network that can quickly meet customer demands across Europe and Africa.

PHCbi products are grouped in four main ranges: Preservation, Incubation, Processing and Sterilization and include ULT, cryogenic and biomedical Freezers, pharmaceutical and blood bank refrigerators, liquid nitrogen cryopreservation freezers, lab tanks, transport containers and vapor shippers and a range of incubation and sterilization solutions.

PHCEU is part of the international PHC Corporation, founded in Japan in 1969, that now operates across more than 120 countries worldwide, focusing on the three core business fields of Medical Devices, Healthcare IT & Life Sciences.

PHC products and facilities are certified to ISO 9001, ISO 14001 and ISO 13485 standards for quality, environmental management and medical devices.

PHC can provide turnkey solutions for validation and qualification in accordance with all current GMPs, GLPs, GCPs, 21 CFR Part 11, PAT, ISO and specific customer requirements and applications.

About World Advanced Therapies Congress 2019

The Advanced Therapies & Regenerative Medicine Congress & Expo is one of Europe’s most important advanced therapies conferences, attracting more than 1000 attendees and featuring 300+ speakers.

The event focuses on all stages of development of cell, gene and immunotherapy – from bioprocessing through clinical translation to reimbursement, market access and delivery to patient. The agenda covers gene therapy, gene edited cell therapies, stem cells & regenerative medicine.

A co-located exhibition features more than 80 exhibitors.

The 14th annual Advanced Therapies Congress is a three day event opening May 15 at the Business Design Center in London, with the latter two days also being Exhibition Days.

The event is organized by Terrapinn Holdings Ltd., with further information at: https://www.terrapinn.com/congress/advanced-therapies-regenerative-medicine/index.stm

Media Contact

Ton Schipperheijn, Communications Manager, PHC Europe BV
Tel: +31 76 5433 833
Email: marketing@eu.phchd.com

Resources

Click on PHCEU at WATRMC 2019 for other information.
Click on PHC Europe to contact the company directly.

PHCbi IncuSafe MCO-170AICUVD CO2 Incubator with inbuilt UV lamp, Dual heat sterilisation and password-protected security door.

PHCbi IncuSafe MCO-170AICUVD CO2 Incubator with inbuilt UV lamp, Dual heat sterilisation and password-protected security door.


Supplier Information
Supplier: PHC Europe BV
Address: Nijverheidsweg 120, 4879 AZ Etten-Leur, The Netherlands
Tel: +31 76 543 3833
Fax: +31 76 541 3732
Website: www.phchd.com/eu/biomedical


Comments are closed.